Alvéole (Paris, France) was founded in 2010 by two researchers from CNRS in collaboration with Quattrocento, a “creator of young innovative companies” in the life sciences field that allows academic researchers to transform their inventions into commercial products.

Alvéole’s goal is to make the control of living cells the future of cell biology.
A company specialized in devices for controlling the cellular microenvironment, Alvéole provides research laboratories with tools for creating more reliable and reproducible in vitro cell models.